Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. News

Hang Seng Index: Benefiting from policy support, biotechnology stocks have seen three consecutive months of inflows.

The Hang Seng Index company stated that there are signs of improvement in the recent situation of biotechnology stocks, as well as benefitting from policy support and three consecutive months of inflow of funds.

Zhitong FinanceAug 7 01:50 ET

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. subscribed to a structured deposit product with a total amount of 0.2 billion yuan from Shanghai Pudong Development Bank.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349) announced that on July 1, 2024, the company entered into a Pudong Development Bank structured deposit product agreement, agreeing to subscribe to a total amount of RMB 0.2 billion of structured deposit products using its own idle funds generated from daily operations.

新浪港股Aug 1 19:58 ET

Express News | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical - Agreed to Subscribe for Structured Deposit Product for RMB200 Mln

ReutersAug 1 04:46 ET

Shanghai Fudan-Zhangjiang Bio-pharmaceutical Co. Ltd. subscribed to a structured deposit product from Shanghai Pudong Development Bank with a total amount of 0.2 billion yuan.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349) announced that on July 1, 2024, the company signed a Pudong Development Bank structure ...

Zhitong FinanceAug 1 04:46 ET

Express News | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd - Subscription of Structured Deposit Product Under Spd Bank

ReutersAug 1 04:46 ET

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349.HK) held a board of directors meeting on August 12 to review and approve its interim performance.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349.HK) announced that it will hold a board of directors meeting on August 12, 2024 (Monday) to consider and approve (including) the unaudited interim performance of the company and its subsidiaries for the six months ended June 30, 2024 and the declaration of interim dividends (if any).

Gelonghui FinanceJul 29 05:03 ET

FUDANZHANGJIANG: NOTICE OF BOARD MEETING

Hong Kong Stock ExchangeJul 29 05:02 ET · Announcements

Fudan Zhangjiang Bio-Pharmaceutical Enrolls First Subject for Tumor Drug Trial

MT NewswiresJul 25 03:36 ET

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349.HK) announced completion of enrollment of the first participant in Phase I clinical trial of injectable FZ-AD005 antibody conjugate for the treatment of advanced solid tumors.

On July 24th, GLH - Fudan Zhangjiang (01349.HK) announced that the Phase I clinical trial of the injection FZ-AD005 antibody conjugate (anti-DLL3 antibody conjugate BB05) developed by the company for the treatment of advanced solid tumors has recently completed the enrollment of the first subject.

Gelonghui FinanceJul 24 05:08 ET

Fudan, Zhangjiang (688505.SH): Not involved in stem cell transplant-related technology

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. stated on the interactive platform on July 23 that the group mainly engages in innovative research and development, production and marketing of biomedical products, and has not been involved in the technology of stem cell transplantation.

Gelonghui FinanceJul 23 03:34 ET

shanghai fudan-zhangjiang bio-pharmaceutical co. ltd. (01349) will distribute a cash dividend of 0.07 yuan per share on July 12th.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349) announced that it will distribute a cash dividend of 0... per share on July 12, 2024.

Zhitong FinanceJul 5 04:53 ET

Fudan-Zhangjiang to Invest 200 Million Yuan in Structured Deposit Product

MT NewswiresJul 4 05:02 ET

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349.HK) subscribed to 200 million yuan of structured deposit products.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (01349.HK) announced on July 3 that the company has recently entered into a structured deposit product agreement with Ping An Bank. They have agreed to subscribe to a structured deposit product with a total amount of RMB 200 million using their own idle funds generated from daily operations.

Gelonghui FinanceJul 3 09:11 ET

Express News | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical- Co to Subscribe for Structured Deposit Product of RMB200 Mln

ReutersJul 3 09:11 ET

Express News | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical - Entered Into Spd Bank Structured Deposit Product Agreement With Shanghai Pudong Development Bank

ReutersJul 2 05:24 ET

Express News | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical - Agreed to Subscribe for Structured Deposit Product With Amount of RMB180 Mln

ReutersJul 2 05:21 ET

Express News | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical - Subscription of Structured Deposit Product Under Bank of China

ReutersJul 2 05:20 ET

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349) cancels part of the raised funds special account.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349) announced that the "Acquisition of Minority Equity Interest in Fudan-Zhangjiang, Taizhou" fundraising project has been completed...

Zhitong FinanceJul 2 05:17 ET

FUDANZHANGJIANG: POLL RESULTS OF 2023 ANNUAL GENERAL MEETING; AND DISTRIBUTION OF FINAL DIVIDEND

Hong Kong Stock ExchangeJun 27 06:50 ET · Announcements

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349) will distribute a final dividend of 0.07 yuan per share on August 26th.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349) announced that it will distribute dividends as of January 2023 on August 26, 2024...

Zhitong FinanceJun 27 06:42 ET